Notably, 60%–90% of post‐transplant PFIC1 patients develop hepatic steatosis or steatohepatitis [7, 8], a condition recently linked to intestinal deficiency of ATP8B1 [9]. Here, ATP8B1 is linked to fatty liver disease.